We’re committed to our mission of finding new treatments that may help improve the lives of people with cancerCancerAbnormal cells that grow out of control [may invade other tissues and may spread into other parts of the body]; Also called malignancy.. Our clinical trials for prostate cancer study investigational medications alone, or in combination with other study medications, or standard of careStandard of care (Standard Treatment)Accepted or approved treatment for a condition (disease or illness); treatment usually given to people for a condition (disease or illness) at the time; the treatment for a condition that is accepted and widely used by health care professionals at the time therapy. We perform these trials to see if they can help prevent, find, or treat cancer.

Prostate cancer begins when cellsCellThe smallest unit of life; what all tissues are made up of inside the prostate gland start to grow rapidly. As more cancerCancerAbnormal cells that grow out of control [may invade other tissues and may spread into other parts of the body]; Also called malignancy. cells grow, they form a tumorTumorA mass or growth that forms in the body that can be cancer (malignant) or not cancer (benign). Also called neoplasm and can potentially spread to other areas of the body.

Cancer that has spread beyond the prostate is known as metastatic prostate cancer. Male hormonesHormonesChemical messengers that travel in the bloodstream to tissues and organs and help control processes such as growth, sexual and other functions (such as testosterone) help prostate cancer grow, so men with metastatic prostate cancer usually get hormone therapy as their first treatment. This treatment aims to lower the body’s levels of male hormones to shrink the cancer in the prostate and other areas where it has spread. However, prostate cancer may eventually grow and require more treatments to help stop or slow down the disease. This is when the prostate cancer is called metastatic castration resistant prostate cancer (mCRPC).